Jangra, S., Ye, C., Rathnasinghe, R., Stadlbauer, D., Alshammary, H., Amoako, A. A., . . . Schotsaert, M. (2021). SARS-CoV-2 spike E484K mutation reduces antibody neutralisation. The Lancet. Microbe, 2(7), e283-e284. https://doi.org/10.1016/S2666-5247(21)00068-9
Chicago Style (17th ed.) CitationJangra, Sonia, et al. "SARS-CoV-2 Spike E484K Mutation Reduces Antibody Neutralisation." The Lancet. Microbe 2, no. 7 (2021): e283-e284. https://doi.org/10.1016/S2666-5247(21)00068-9.
MLA (9th ed.) CitationJangra, Sonia, et al. "SARS-CoV-2 Spike E484K Mutation Reduces Antibody Neutralisation." The Lancet. Microbe, vol. 2, no. 7, 2021, pp. e283-e284, https://doi.org/10.1016/S2666-5247(21)00068-9.
Warning: These citations may not always be 100% accurate.